Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.62 -0.02 (-1.22%)
At close: Oct 1, 2026 · 4:00 PM EDT

Processa Pharmaceuticals (PCSA) Liabilities and Shareholders Equity (2012 - 2026)

Updated

Processa Pharmaceuticals' Liabilities and Shareholders Equity came in at $2.07 million for Q2 2026, down 74.7% from $8.18 million a year earlier and down 54.2% from the prior quarter.

Analysis

Processa Pharmaceuticals (PCSA) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

At the end of FY2025, Processa Pharmaceuticals' Liabilities and Shareholders Equity was $7.81 million, up 142.0% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -20.9% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $3.23 million in FY2024 (-44.2%), $5.79 million in FY2023 (-32.9%), $8.62 million in FY2022 (-67.4%) and $26.46 million in FY2021 (+5.0%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q3 2017.
  • Year-over-year, Liabilities and Shareholders Equity increased in three of the last eight quarters, with an average decline of 1.5%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q3 2021 (growth of 202.7%), and the weakest in Q2 2026 (a decline of 74.7%).
  • Business Quant data shows PCSA's Liabilities and Shareholders Equity at $4.52 million (Q1 2026), $7.81 million (Q4 2025) and $7.58 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Processa Pharmaceuticals 4.58 Mn 4.58 Mn - 2.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.07 Mn
Mar 31, 2026 4.52 Mn
Dec 31, 2025 7.81 Mn
Sep 30, 2025 7.58 Mn
Jun 30, 2025 8.18 Mn
Mar 31, 2025 4.81 Mn
Dec 31, 2024 3.23 Mn
Sep 30, 2024 4.94 Mn
Jun 30, 2024 7.60 Mn
Mar 31, 2024 9.94 Mn
Dec 31, 2023 5.79 Mn
Sep 30, 2023 8.08 Mn
Jun 30, 2023 10.09 Mn
Mar 31, 2023 12.43 Mn
Dec 31, 2022 8.62 Mn
Sep 30, 2022 18.60 Mn
Jun 30, 2022 21.66 Mn
Mar 31, 2022 24.30 Mn
Dec 31, 2021 26.46 Mn
Sep 30, 2021 29.03 Mn
API Access

Processa Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PCSA&period=max&api_key=YOUR_API_KEY